STOCKSCOUTER

StockScouter Premium

StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance

IRWD IRONWOOD PHARMACEUTICALS INCORPORATED StockScouter® Report

3

StockScouter® Score

IRONWOOD PHARMACEUTICALS INCORPORATED, a small cap value company in the healthcare sector, is expected to slightly underperform the market over the next six months with higher than average risk

10 is the best possible rating. Learn more.

Summary

Positives

  • Earnings growth in the past year has accelerated rapidly compared to earnings growth in the past three years. Positive

 

Concerns

  • Executives, board directors or major shareholders have both bought and sold shares recently. Neutral
  • Analysts have issued conflicting earnings estimate revisions for IRWD. Neutral

 

Short-term Outlook

Over the next 1-2 months, StockScouter forecasts that small cap stocks will be in favor, value stocks will be in favor, and healthcare stocks will be in favor.

Expected Risk/Return

Progress: 100% done.
Progress: 40% done.
Low
High

Core Model Grades

A
C
C
A

Previous Ratings

5
3
3